|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
111,521,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxxinity is a biotechnology company. Co.'s pipeline consists of five chronic disease product candidates including UB-311, which targets toxic forms of aggregated Ab in the brain to fight Alzheimer's Disease; UB-312, which targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's Disease and other synucleinopathies; an anti-tau product candidate that has the potential to address various neurodegenerative conditions; UB-313, which targets Calcitonin Gene-Related Peptide to fight migraines; and Anti-PCSK9, which targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
362,934 |
Total Buy Value |
$0 |
$0 |
$0 |
$776,028 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
9 |
Total Shares Sold |
0 |
0 |
96,936 |
1,191,214 |
Total Sell Value |
$0 |
$0 |
$168,588 |
$3,463,338 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
6 |
20 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sloss Dakin |
10% Owner |
|
2023-09-08 |
4 |
S |
$1.67 |
$38,196 |
I/I |
(22,872) |
3,594,122 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2023-09-08 |
4 |
S |
$1.67 |
$41,899 |
D/D |
(25,089) |
8,713,663 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2023-09-07 |
4 |
S |
$1.79 |
$33,092 |
I/I |
(18,516) |
3,604,471 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2023-09-07 |
4 |
S |
$1.79 |
$36,302 |
D/D |
(20,312) |
8,738,752 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2023-09-06 |
4 |
S |
$1.88 |
$9,108 |
I/I |
(4,839) |
3,612,849 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2023-09-06 |
4 |
S |
$1.88 |
$9,991 |
D/D |
(5,308) |
8,759,064 |
|
- |
|
Diamandis Peter |
Director |
|
2023-04-26 |
4 |
OE |
$0.57 |
$300,816 |
D/D |
475,537 |
906,141 |
|
- |
|
Smith James Alan |
Director |
|
2023-02-01 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
54,202 |
|
- |
|
Smith James Alan |
Director |
|
2023-02-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,268 |
|
- |
|
Smith James Alan |
Director |
|
2023-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,058 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2023-01-23 |
4 |
S |
$3.35 |
$1,358,044 |
D/D |
(405,217) |
8,764,372 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2023-01-23 |
4 |
S |
$3.35 |
$319,975 |
I/I |
(95,475) |
2,065,027 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-12-02 |
4 |
S |
$2.57 |
$28,561 |
D/D |
(11,121) |
9,169,589 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-12-02 |
4 |
S |
$2.57 |
$6,729 |
I/I |
(2,620) |
2,160,502 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-12-01 |
4 |
S |
$2.97 |
$805,224 |
D/D |
(270,964) |
9,180,710 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-12-01 |
4 |
S |
$2.97 |
$189,722 |
I/I |
(63,843) |
2,163,122 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-09-06 |
4 |
S |
$2.40 |
$60,656 |
D/D |
(25,243) |
9,451,674 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-09-06 |
4 |
S |
$2.40 |
$29,111 |
I/I |
(12,115) |
1,473,100 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-08-25 |
4 |
S |
$2.33 |
$53,047 |
D/D |
(22,757) |
9,476,917 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-08-25 |
4 |
S |
$2.33 |
$25,462 |
I/I |
(10,923) |
1,477,034 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-08-24 |
4 |
S |
$2.39 |
$199,930 |
D/D |
(83,786) |
9,499,674 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-08-24 |
4 |
S |
$2.39 |
$95,959 |
I/I |
(40,214) |
1,480,581 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-08-23 |
4 |
S |
$2.45 |
$82,658 |
D/D |
(33,785) |
9,583,460 |
|
- |
|
Sloss Dakin |
10% Owner |
|
2022-08-23 |
4 |
S |
$2.45 |
$39,672 |
I/I |
(16,215) |
1,493,639 |
|
- |
|
Guirakhoo Farshad |
(Former) Chief Scientific Off. |
|
2022-08-22 |
4 |
OE |
$0.57 |
$1,505 |
D/D |
2,640 |
68,645 |
|
- |
|
81 Records found
|
|
Page 1 of 4 |
|
|